The present technology generally relates to clot removal systems including catheters (e.g., large bore aspiration catheters) having a steerable distal portion to, for example, facilitate positioning of the catheter in hard-to-reach regions of the vasculature of a patient.
Thromboembolic events are characterized by an occlusion of a blood vessel. Thromboembolic disorders, such as stroke, pulmonary embolism, heart attack, peripheral thrombosis, atherosclerosis, and the like, affect many people. These disorders are a major cause of morbidity and mortality.
When an artery is occluded by a clot, tissue ischemia develops. The ischemia will progress to tissue infarction if the occlusion persists. Infarction does not develop or is greatly limited if the flow of blood is reestablished rapidly. Failure to reestablish blood flow can lead to the loss of limb, angina pectoris, myocardial infarction, stroke, or even death.
In the venous circulation, occlusive material can also cause serious harm. Blood clots can develop in the large veins of the legs and pelvis, a common condition known as deep venous thrombosis (DVT). DVT arises most commonly when there is a propensity for stagnated blood (e.g., long distance air travel, immobility, etc.) and clotting (e.g., cancer, recent surgery, such as orthopedic surgery, etc.). DVT causes harm by: (1) obstructing drainage of venous blood from the legs leading to swelling, ulcers, pain, and infection, and (2) serving as a reservoir for blood clots to travel to other parts of the body including the heart, lungs, brain (stroke), abdominal organs, and/or extremities.
In the pulmonary circulation, the undesirable material can cause harm by obstructing pulmonary arteries—a condition known as pulmonary embolism. If the obstruction is upstream, in the main or large branch pulmonary arteries, it can severely compromise total blood flow within the lungs, and therefore the entire body, and result in low blood pressure and shock. If the obstruction is downstream, in large to medium pulmonary artery branches, it can prevent a significant portion of the lung from participating in the exchange of gases to the blood resulting in low blood oxygen and buildup of blood carbon dioxide.
There are many existing techniques to reestablish blood flow through an occluded vessel. One common surgical technique, an embolectomy, involves incising a blood vessel and introducing a balloon-tipped device (such as the Fogarty catheter) to the location of the occlusion. The balloon is then inflated at a point beyond the clot and used to translate the obstructing material back to the point of incision. The obstructing material is then removed by the surgeon. Although such surgical techniques have been useful, exposing a patient to surgery may be traumatic and best avoided when possible. Additionally, the use of a Fogarty catheter may be problematic due to the possible risk of damaging the inner lining of the vessel as the catheter is being withdrawn.
Percutaneous methods are also utilized for reestablishing blood flow. A common percutaneous technique is referred to as balloon angioplasty where a balloon-tipped catheter is introduced to a blood vessel (e.g., typically through an introducing catheter). The balloon-tipped catheter is then advanced to the point of the occlusion and inflated to dilate the stenosis. Balloon angioplasty is appropriate for treating vessel stenosis, but it is generally not effective for treating acute thromboembolisms as none of the occlusive material is removed and the vessel will re-stenos after dilation. Another percutaneous technique involves placing a catheter near the clot and infusing streptokinase, urokinase, or other thrombolytic agents to dissolve the clot. Unfortunately, thrombolysis typically takes hours to days to be successful. Additionally, thrombolytic agents can cause hemorrhage and in many patients the agents cannot be used at all.
Various devices exist for performing a thrombectomy or removing other foreign material. However, such devices have been found to have structures which are either highly complex, cause trauma to the treatment vessel, or lack sufficient retaining structure and thus cannot be appropriately fixed against the vessel to perform adequately. Furthermore, many of the devices have highly complex structures that lead to manufacturing and quality control difficulties as well as delivery issues when passing through tortuous or small diameter catheters. Less complex devices may allow the user to pull through the clot, particularly with inexperienced users, and such devices may not completely capture and/or collect all the clot material.
Many aspects of the present technology can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale. Instead, emphasis is placed on illustrating clearly the principles of the present disclosure.
The present technology is generally directed to clot removal systems including aspiration catheters having a deflectable/steerable distal portion for improved flexibility through hard-to-reach (e.g., tortuous) vascular anatomy of a patient, and associated systems and methods. In some embodiments, a clot removal system in accordance with embodiments of the present technology includes (i) an aspiration catheter having a proximal region and a distal region and (ii) a handle coupled to the proximal region of the catheter and having an actuator. The distal region of the catheter can include a deflectable member, and the clot removal system can include a pull wire extending between the actuator and the deflectable member. Actuation of the actuator is configured to pull the pull wire to deflect the deflectable member to deflect the distal region relative to the proximal region. The deflection can facilitate steering of the catheter to the hard-to-reach portions of the anatomy of the patient.
In some embodiments, the deflectable member includes a proximal ring, a distal ring, and a tube portion extending between the proximal and distal rings. The proximal ring can include an annular member coupled (e.g., welded) thereto and configured to slidably receive the pull wire. The distal ring can be configured to be fixedly attached (e.g., welded) to the pull wire. The tube portion can include a plurality of openings (e.g., circumferentially extending openings) that define a plurality of ribs. The ribs can flex away from each other when the actuator is actuated to pull the pull wire. In some embodiments, the tube portion further includes a spine extending between the proximal and distal rings and generally aligned with the pull wire.
In some embodiments, the catheter further includes an intermediate region between the proximal and distal regions. The catheter can include a braid of wires extending along the proximal and distal regions, and a coil extending over the braid along the intermediate region.
In some aspects of the present technology, the catheter is configured to be steered to and positioned in difficult-to-reach regions of the anatomy of a patient while still having a relatively large size (e.g., 20 French, 24 French, greater than 24 French). More particularly, the catheter can have an improved torque response and flexibility compared to conventional catheters having the same size. For example, the braid can provide good torque response along the proximal and intermediate regions of the catheter. Additionally, the deflectable region can be configured (e.g., shaped, sized) to be positioned within and steered/flexed into the difficult-to-reach regions of the anatomy. Further, the coil can provide increased hoop strength at the intermediate region while still allowing the catheter to flex. For example, the coil can inhibit or even prevent kinking or other unwanted movement of the catheter when the catheter is aspirated during a clot removal procedure.
Certain details are set forth in the following description and in
The terminology used below is to be interpreted in its broadest reasonable manner, even though it is being used in conjunction with a detailed description of certain examples of embodiments of the technology. Indeed, certain terms may even be emphasized below; however, any terminology intended to be interpreted in any restricted manner will be overtly and specifically defined as such in this Detailed Description section.
The accompanying Figures depict embodiments of the present technology and are not intended to be limiting of its scope unless expressly indicated. The sizes of various depicted elements are not necessarily drawn to scale, and these various elements may be enlarged to improve legibility. Component details may be abstracted in the Figures to exclude details such as position of components and certain precise connections between such components when such details are unnecessary for a complete understanding of how to make and use the present technology. Many of the details, dimensions, angles and other features shown in the Figures are merely illustrative of particular embodiments of the disclosure. Accordingly, other embodiments can have other details, dimensions, angles and features without departing from the present technology. In addition, those of ordinary skill in the art will appreciate that further embodiments of the present technology can be practiced without several of the details described below.
With regard to the terms “distal” and “proximal” within this description, unless otherwise specified, the terms can reference a relative position of the portions of a catheter subsystem with reference to an operator and/or a location in the vasculature. Also, as used herein, the designations “rearward,” “forward,” “upward,” “downward,” and the like are not meant to limit the referenced component to a specific orientation. It will be appreciated that such designations refer to the orientation of the referenced component as illustrated in the Figures. The systems of the present technology can be used in any orientation suitable to the user.
Referring to
In some embodiments, the proximal region 121 has a first length, the intermediate region 122 has a second length less than the first length, and the distal region 123 has a third length less than the first and second lengths. For example, the first length can be between about 50-100 millimeters (e.g., about 80 millimeters), the second length can be between about 10-50 millimeters (e.g., about 25 millimeters), and the third length can be between about 1.0-10 millimeters (e.g., about 4.2 millimeters). In some embodiments, the transition region 124 can have a length of between about 0.1-5.0 millimeters (e.g., about 0.6 millimeters), the deflectable region 125 can have a length of between about 1.0-10 millimeters (e.g., about 3.0 millimeters), and the tip region 126 can have a length of between about 0.1-5.0 millimeters (e.g., about 0.6 millimeters). In other embodiments, the lengths of one or more of the regions 121-126 can be different. In some embodiments, the catheter 120 can have varying flexibilities, shapes, thicknesses, and/or other properties in/along the various regions 121-126.
In the illustrated embodiment, the handle 130 includes and/or is coupled to a valve 132. The valve 132 can include a branch or side port 133 configured to fluidly couple the lumen 127 of the catheter 120 to the tubing assembly 110, and can be integral with or coupled to the proximal region 121 of the catheter 120. In some embodiments, the valve 132 is a hemostasis valve that is configured to maintain hemostasis during a clot removal procedure by inhibiting or even preventing fluid flow in the proximal direction through the valve 132 as various components such as delivery sheaths, pull members, guidewires, interventional devices, other aspiration catheters, and so on are inserted through the valve 132 to be delivered through the catheter 120 to a treatment site in a blood vessel. In some embodiments, the valve 132 can be a valve of the type disclosed in U.S. patent application Ser. No. 16/117,519, filed Aug. 30, 2018, and titled “HEMOSTASIS VALVES AND METHODS OF USE,” which is incorporated herein by reference in its entirety.
In the illustrated embodiment, the tubing assembly 110 fluidly couples the catheter 120 to a pressure source 102, such as a syringe. The tubing assembly 110 can include one or more tubing sections 112 (individually labeled as a first tubing section 112a and a second tubing section 112b), at least one fluid control device 114 (e.g., a valve), and at least one connector 116 (e.g., a Toomey tip connector) for fluidly coupling the tubing assembly 110 to the pressure source 102 and/or other suitable components. In some embodiments, the fluid control device 114 is a stopcock that is fluidly coupled to (i) the side port 133 of the valve 132 via the first tubing section 112a and (ii) the connector 116 via the second tubing section 112b. The fluid control device 114 is externally operable by a user to regulate the flow of fluid therethrough and, specifically, from the lumen 127 of the catheter 120 to the pressure source 102. In some embodiments, the connector 116 is a quick-release connector (e.g., a quick disconnect fitting) that enables rapid coupling/decoupling of the catheter 120 and the fluid control device 114 to/from the pressure source 102.
In the illustrated embodiment, the handle 130 includes a housing 134 and an actuator 136. The actuator 136 can be operably coupled to the catheter 120 and movable (e.g., rotatable) relative to the housing 134 to deflect (e.g., steer, flex) the deflectable region 125 from (i) a first position (e.g., an unflexed position, an aligned position) shown in
In some embodiments, the outer sheath 240 can be formed from a plastic material, elastomeric material, and/or thermoplastic elastomer (TPE) material. In some embodiments, the outer sheath 240 can be formed from a TPE manufactured by Arkema S.A., of Colombes, France, such as the TPEs manufactured under the trademark “Pebax.” In some embodiments, the outer sheath 240 can have a varying hardness (e.g., durometer), thickness, flexibility, rigidity, and/or other property in one or more of the different regions 121-126. For example, the outer sheath 240 can have (i) a first hardness along the proximal region 121 of between about 65 D-75 D (e.g., about 72 D), (ii) a second hardness along the intermediate region 122 of between about 30 D-40 D (e.g., about 35 D), (iii) a third hardness along the transition region 124 of between about 50 D-60 D (e.g., about 55 D), (iv) a fourth hardness along the deflectable region of between about 20 D-30 D (e.g., about 25 D), and (v) a fifth hardness along the tip region 126 of between about 50 D-60 D (e.g., about 55 D). In other embodiments, the outer sheath 240 can have a different hardness or other property along one or more of the regions 121-126.
The inner liner 242 can be formed of a lubricious material that facilitates the movement (e.g., distal advancement, proximal retraction) of various components through the lumen 127, such as delivery sheaths, pull members, guidewires, interventional devices, other aspiration catheters, and the like. In some embodiments, the inner liner 242 can be formed from a polymer material, a fluoropolymer material (e.g., polytetrafluoroethylene (PTFE)), and/or another material having a high degree of lubricity. In some embodiments, the inner liner 242 can define a diameter D (
The catheter 120 can further include a braid 244 extending along the proximal region 121 and the intermediate region 122 between the outer sheath 240 and the inner liner 242. In some embodiments, the braid 244 terminates at or before the distal region 123 such that the braid 244 does not extend along the transition region 124, the deflectable region 125, or the tip region 126. In the illustrated embodiment, the catheter 120 further includes a coil 346 (
The braid 244 can include wires, filaments, threads, sutures, fibers, or the like (collectively “wires 248”) that have been woven or otherwise coupled, attached, formed, and/or joined together at a plurality of interstices 249. Accordingly, the braid 244 can also be referred to as a braided structure, a braided filament structure, a braided filament mesh structure, a mesh structure, a mesh filament structure, and the like. In some embodiments, the wires 248 can comprise metals, polymers, and/or composite materials. In some embodiments, individual ones of the wires 248 can be rolled flat wires having a cross-sectional dimension of between about 0.0005-0.005 inch (e.g., about 0.002 inch) by about 0.002-0.005 inch (e.g., about 0.0033 inch).
In the illustrated embodiment, the coil 346 is a single wire wound around the braid 244 and the inner liner 242 along the intermediate region 122. In other embodiments, the coil 346 can include more than one wire wound about the braid 244. For example, the coil 346 can include multiple wires wound over one another and/or multiple wires wound to at least partially overlap one another to form a braided or overlapping coil structure on the braid 244. In other embodiments, the coil 346 can be formed directly over the inner liner 242, and the braid 244 can be formed over the coil 346. The coil 346 can be formed from a metallic or other suitably strong material, such as nickel-titanium alloys (e.g. nitinol), platinum, cobalt-chrome alloys, stainless steel, tungsten, and/or titanium.
Referring again to
Referring to
Referring to
Referring to
In the illustrated embodiment, the handle 130 includes a hollow tube member 574 positioned at least partially within the proximal chamber 570. The tube member 574 can include a proximal end portion 571a and a distal end portion 571b coupled to (e.g., secured to) the actuator 136. The tube member 574 can define a lumen 573 extending between the proximal and distal end portions 571a-b, and the tube member 574 can have a threaded inner surface 575 extending at least partially along the lumen 573. The actuator 136 can be a rotatable member, such as a wheel, grip wheel, or dial that is rotatable relative to the housing 134 to rotate the tube member 574 within the proximal chamber 570.
In the illustrated embodiment, the handle 130 further includes a catheter support or guide 576 extending at least partially through (i) the distal chamber 572, (ii) the actuator 136 (e.g., through a lumen in the actuator), (iii) the lumen 573 of the tube member 574, and (iv) the proximal chamber 570. In some embodiments, the catheter guide 576 defines a lumen 577 extending therethrough and includes a proximal flange portion 578 that can be secured to the housing 134. In some embodiments, the catheter guide 576 is fixed to the housing 134 such that the catheter guide 576 does not rotate when the actuator 136 is actuated to move the tube member 574. The proximal region 121 of the catheter 120 can extend into the handle 130, through the lumen 577 in the catheter guide 576, and to the valve 132. The proximal terminus 529 of the catheter 120 can be fluidly coupled to the valve 132. Accordingly, the catheter 120, the catheter guide 576, and the tube member 574 can be coaxially aligned. In other embodiments, the catheter guide 576 can be omitted.
The handle 130 can further include a shuttle member 580 positioned at least partially in the lumen 573 of the tube member 574 over the catheter guide 576 (e.g., over an outer surface thereof). In some embodiments, the shuttle member 580 is a hollow member slidably positioned over the catheter guide 576 and movable relative to the catheter 120. In the illustrated embodiment, the shuttle member 580 includes a threaded portion 582 having a threaded outer surface 583 and an anchor portion 584 extending from the threaded portion 582. The threaded outer surface 583 is configured to engage the threaded inner surface 575 of the tube member 574 such that, for example, movement of the tube member 574 drives the shuttle member 580 to move through the lumen 573 over the catheter guide 576 and relative to the catheter 120.
In the illustrated embodiment, the pull wire 458 extends along the catheter 120 into the handle 130 where it secured to the anchor portion 584 of the shuttle member 580. More specifically, the pull wire 458 can extend from the distal ring 454 of the deflectable member 450 (
Referring to
In other embodiments, the handle 130 can include other features for moving/driving the shuttle member 580 through the housing 134 to tension the pull wire 458. For example, the actuator 136 can be a slider, clip, or other actuator movable relative to the housing 134.
Referring to
In the illustrated embodiment, the tube portion 656 includes a plurality of openings 651 (identified individually as first openings 651a and second openings 651b) extending partially about a circumference of the tube portion 656 to define a plurality of ribs 655 (identified individually as first ribs 655a and second ribs 655b). In some embodiments, the first openings 651a are generally elongate openings that extend (i) generally parallel to one another and (ii) circumferentially about a longitudinal axis M of the deflectable member 650 such that, for example, the first ribs 655a have a generally similar or identical shape. Similarly, the second openings 651b can each have an elongate tapered shape and can extend (i) generally parallel to one another and (ii) circumferentially about the longitudinal axis M of the deflectable member 650 such that, for example, the second ribs 655b have a generally similar or identical shape. In the illustrated embodiment, the second ribs 655b have a smaller dimension (e.g. width) in a direction along the longitudinal axis M than the first ribs 655a. Accordingly, the second ribs 655b can be relatively more flexible than the first ribs 655a.
In some embodiments, the pull wire 458 can extend over/adjacent to the first ribs 655a. Accordingly, referring to
In some embodiments, all or a portion of the deflectable member 650 can be manufactured as a single integral piece. For example,
With reference to
Accordingly, with reference to
In some aspects of the present technology, moving the deflectable region 125 to the second position helps the catheter 120 flex/bend around the bend 790 and into the hard-to-reach region of the blood vessel BV distal thereof. In some embodiments, before advancing the catheter 120 to the position shown in
Access to the pulmonary vessels can be achieved through the patient's vasculature, for example, via the femoral vein. In some embodiments, the clot removal system 100 can include an introducer (e.g., a Y-connector with a hemostasis valve; not shown) that can be partially inserted into the femoral vein. A guidewire (not shown) can be guided into the femoral vein through the introducer and navigated through the right atrium, the tricuspid valve, the right ventricle, the pulmonary valve, and into the main pulmonary artery. Depending on the location of the clot material PE, the guidewire can be guided to one or more of the branches of the right pulmonary artery and/or the left pulmonary artery. In some embodiments, the guidewire can be extended entirely or partially through the clot material PE. In other embodiments, the guidewire can be extended to a location just proximal of the clot material PE. After positioning the guidewire, the catheter 120 can be placed over the guidewire and advanced to the position proximate to the clot material PE as illustrated in
With reference to
Opening of the fluid control device 114 instantaneously or nearly instantaneously applies the stored vacuum pressure to the tubing assembly 110 and the catheter 120, thereby generating a suction pulse throughout the catheter 120. In particular, the suction is applied at the tip region 126 of the catheter 120 to suck/aspirate at least a portion of the clot material PE into the lumen 127 of the catheter 120, as shown in
Sometimes, as shown in
In some aspects of the present technology, the relatively great flexibility and torquability of the catheter 120 allow the catheter 120 to be positioned in difficult-to-reach areas of the blood vessel BV (or elsewhere in the vasculature of the patient) without decreasing the size of the lumen 127 and while keeping the lumen 127 of constant diameter throughout. It is expected that the increased size of the lumen 127 will provide greater suction forces over a smaller period of time (e.g., will provide a larger vacuum impulse). In some embodiments, the greater suction forces can facilitate the removal of clot material from a blood vessel of a patient even where the clot material is strongly lodged or attached within the blood vessel (e.g., a chronic clot). Accordingly, in contrast to conventional catheters, the catheter 120 can be used to generate greater aspirational forces for improved clot removal in hard-to-reach places of the vasculature. In additional aspects of the present technology, the coil 336 (
Although described in the context of removing clot material from pulmonary blood vessels, in other embodiments the clot removal system 100 can be used to remove clot from other locations in the body of the patient. For example, the clot removal system 100 can used to aspirate or otherwise remove clot material (e.g., stationary or in transit) and/or vegetation from the heart (e.g., the right atrium, tricuspid valve, pulmonary valve), the vena cava, the renal arteries, and so on.
Several aspects of the present technology are set forth in the following examples:
1. An aspiration catheter, comprising:
2. The aspiration guide catheter of example 1 wherein the tube portion includes a spine extending in a direction between the proximal and distal rings, wherein the ribs extend away from the spine, and wherein the spine is configured to extend generally parallel to and over the pull wire.
3. The aspiration catheter of example 1 or example 2 wherein the proximal region and the distal region define a lumen having a diameter of 20 French or greater.
4. The aspiration catheter of any one of examples 1-3, further comprising an intermediate region between the proximal and distal regions, wherein the proximal region and the intermediate region include a braid of wires extending therethrough.
5. The aspiration catheter of example 4 wherein the intermediate region includes a wire coiled around the braid.
6. The aspiration catheter of any one of examples 1-5 wherein the tube portion extends along a longitudinal axis in a relaxed state, and wherein the openings extend circumferentially about the longitudinal axis and generally parallel to one another in the relaxed state.
7. The aspiration catheter of any one of examples 1-6 wherein the proximal ring includes an annular member configured to slidably receive the pull wire therethrough.
8. A clot removal system, comprising:
9. The clot removal system of example 8 wherein the aspiration catheter extends along an axis, and wherein the actuation of the actuator is configured to deflect the distal region of the aspiration catheter away from the axis by about 90 degrees or greater.
10. The clot removal system of example 8 or example 9 wherein the aspiration guide catheter has a size of 20 French or greater.
11. The clot removal system of any one of examples 8-10 wherein the deflectable member has a tubular shape that extends along a longitudinal axis, and wherein the deflectable member includes (a) a spine extending parallel to the longitudinal axis and (b) a plurality of ribs extending from the spine and circumferentially about the longitudinal axis.
12. The clot removal system of example 11 wherein the deflectable member has a distal portion and a proximal portion, and wherein the pull wire is attached to the distal portion of the deflectable member.
13. The clot removal system of example 12 wherein the actuation of the actuator is configured pull the distal portion proximally relative to the proximal portion.
14. The clot removal system of example 12 or example 13 wherein the ribs define a plurality of openings therebetween, and wherein the actuation of the actuator is configured pull the distal portion of the deflectable member proximally relative to the proximal portion to bend the spine and increase a size of the openings.
15. The clot removal system of any one of examples 8-14 wherein the aspiration catheter further includes—
16. The clot removal system of example 15 wherein—
17. A method of removing clot material from a blood vessel, the method comprising:
18. The method of example 17 wherein actuating the handle to deflect the distal portion of the aspiration catheter includes deflecting the distal portion of the aspiration catheter away from the longitudinal axis in a deflection direction, and wherein the method further comprises rotating the aspiration catheter such that the deflection direction is at least partially aligned with a bend in the blood vessel.
19. The method of example 17 or example 18 wherein the aspiration catheter has a size of 20 French or greater.
20. The method of any one of examples 17-19 wherein the aspiration catheter includes a deflectable member positioned in the distal portion, and wherein actuating the handle includes rotating an actuator of the handle to pull a pull wire coupled to the deflectable portion proximally to deflect the deflectable member to deflect the distal portion of the aspiration catheter.
The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology as those skilled in the relevant art will recognize. For example, although steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments.
From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with some embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
This application claims the benefit of U.S. Provisional Patent Application No. 63/115,515, filed Nov. 18, 2020, and titled “CATHETERS HAVING STEERABLE DISTAL PORTIONS, AND ASSOCIATED SYSTEMS AND METHODS,” which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63115515 | Nov 2020 | US |